Developing vaccines against foot-and-mouth disease and some other exotic viral diseases of livestock

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 366, Issue 1579, 2011, Pages 2774-2781

  Paton, David J ^a   Taylor, Geraldine ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

African swine fever; Bluetongue; Foot and mouth disease; Livestock viral vaccines; Peste des petits ruminants; Rift valley fever

Indexed keywords

AGRICULTURAL DEVELOPMENT; CLIMATE CHANGE; COST-BENEFIT ANALYSIS; DISEASE SPREAD; DISEASE TREATMENT; DRUG DEVELOPMENT; EMERGENCE; FOOD SECURITY; FOOT AND MOUTH DISEASE; GLOBALIZATION; INVASIVE SPECIES; LIVESTOCK; PRIORITIZATION; PUBLIC HEALTH; TRADE-OFF; VACCINATION; VACCINE; VIRAL DISEASE;

NORTHERN EUROPE; UNITED KINGDOM;

ANIMALIA; PESTE-DES-PETITS-RUMINANTS VIRUS; SUIDAE;

EID: 80052435221     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0107     Document Type: Review

References (66)

1. Thomson, G. R., Perry, B. D., Catley, A., Leyland, T. J., Penrith, M. L. & Donaldson, A. I. 2006 Certification for regional and international trade in livestock commodities: the need to balance credibility and enterprise. Vet. Rec. 159, 53-57. (doi:10.1136/vr.159.2.53)
2. Paton, D. J., Sinclair, M. & Rodríguez, R. 2010 Qualitative assessment of the commodity risk for spread of footand-mouth disease associated with international trade in deboned beef. Transbound Emerg. Dis. 57, 115-134. (doi:10.1111/j.1865-1682.2010.01137.x)
3. CAST. 2005 Global risks of infectious animal diseases. Issue Paper No. 28, Council for Agricultural Science and Technology (ISSN 1070-0021). See http://www.cast-science.org
4. Brugère-Picoux, J. & Chomel, B. 2009 Importation of infectious diseases to Europe via animals and animal products: risks and pathways. Bull. Acad. NatlMed. 193, 1805-1818.
5. O'Brien, D. & Zanker, S. 2007 Animal vaccination and the veterinary pharmaceutical industry. Rev. Sci. Tech. 26, 471-477.
6. Anonymous 1937 Fifth progress report of the Foot-and-Mouth Disease Research Committee. London, UK: Ministry of Agriculture and Fisheries, HMSO.
7. Sangula, A. K., Siegismund, H. R., Belsham, G. J., Balinda, S. N., Masembe, C. & Muwanika, V. B. 2011 Low diversity of foot-and-mouth disease serotype C virus in Kenya: evidence for probable vaccine strain re-introductions in the field. Epidemiol. Infect. 139, 189-196. (doi:10.1017/S0950268810000580)
8. World Organization for Animal Health 2010 Terrestrial animal health code. Paris, France: World Organization for Animal Health. See http://www.oie.int/eng/normes/mcode/en_sommaire.htm.
9. Uttenthal, A., Parida, S., Rasmussen, T. B., Paton, D. J., Haas, B. & Dundon, W.G. 2010 Strategies for differentiating infection in vaccinated animals (DIVA) for foot-andmouth disease, classical swine fever and avian influenza. Exp. Rev. Vaccines 9, 73-87. (doi:10.1586/erv.09.130)
10. Roeder, P. L., Lubroth, J. & Taylor, W. P. 2004 Experience with eradicating rinderpest by vaccination. Dev. Biol. (Basel) 119, 73-91.
11. Banyard, A. C., Parida, S., Batten, C., Oura, C., Kwiatek, O. & Libeau, G. 2010 Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control. J. Gen. Virol. 91, 2885-2897. (doi:10.1099/vir.0.025841-0)
12. Szmaragd, C., Wilson, A. J., Carpenter, S., Wood, J. L. N., Mellor, P. S. & Gubbins, S. 2010 The spread of bluetongue virus serotype 8 in Great Britain and its control by vaccination. PLoS ONE 5, e9353. (doi:10. 1371/journal.pone.0009353)
13. Fogedby, E. 1962 Review of epizootiology and control of foot-and-mouth disease in Europe from 1937 to 1961. European Commission for the Control of Foot-and-Mouth Disease Rome, Italy: Food and Agricultural Organization of the United Nations.
14. Leforban, Y. & Gerbier, G. 2002 Review of the status of foot and mouth disease and approach to control/eradication in Europe and Central Asia. Rev. Sci. Tech. Off. Int. Epiz. 21, 477-492.
15. Correa Melo, E., Saraiva, V. & Astudillo, V. 2002 Review of the status of foot and mouth disease in countries of South America and approaches to control and eradication. Rev. Sci. Tech. 21, 429-436.
16. Paton, D. J., Sumption, K. & Charleston, B. 2009 Options for control of foot-and-mouth disease: knowledge, capability and policy. Phil. Trans. R. Soc. B 364, 2657-2667. (doi:10.1098/rstb.2009.0100)
17. Anonymous 2010 Summary of expert opinion on vaccine and/or diagnostic banks for major animal diseases. European Commission, Health and Consumers Directorate-General, SANCO/7070/2010/summary. See http://ec.europa.eu/food/animal/diseases/strategy/pillars/docs/7070-vaccine-bank-summary_en.pdf.
18. Lombard, M. & Füssel, A. E. 2007 Antigen and vaccine banks: technical requirements and the role of the European antigen bank in emergency foot-and-mouth disease vaccination. Rev. Sci. Tech. 26, 117-134.
19. Costard, S., Wieland, B., de Glanville, W., Jori, F., Rowlands, R., Vosloo, W., Roger, F., Pfeiffer, D. & Dixon, L. K. 2009 African swine fever: how can global spread be prevented? Phil. Trans. R. Soc. B 364, 2683-2696. (doi:10.1098/rstb.2009.0098)
20. Taboga, O. et al. 1997 A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71, 2606-2614.
21. Kitching, P., Hammond, J., Jeggo, M., Charleston, B., Paton, D., Rodriguez, L. & Heckert, R. 2007 Global FMD control-is it an option? Vaccine 25, 5660-5664. (doi:10.1016/j.vaccine.2006.10.052)
22. Grubman, M. J. 2005 Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. Biologicals 33, 227-234. (doi:10.1016/j.biolo gicals.2005.08.009)
23. Li, Z., Yin, X., Yi, Y., Li, X., Li, B., Lan, X., Zhang, Z. & Liu, J. 2011 FMD subunit vaccine produced using a silkworm-baculovirus expression system: protective efficacy against two type Asia1 isolates in cattle. Vet. Microbiol. 149, 99-103. (doi:10.1016/j.vetmic.2010.10.022)
24. Paton, D. J., De Clercq, K., Greiner, M., Dekker, A., Brocchi, E., Bergmann, I., Sammin, D. J., Gubbins, S. & Parida, S. 2006 Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. Vaccine 24, 6503-6512. (doi:10.1016/j.vaccine. 2006.06.032)
25. Keeling, M. J., Woolhouse, M. E., May, R. M., Davies, G. & Grenfell, B. T. 2003 Modelling vaccination strategies against foot-and-mouth disease. Nature 421, 136-142. (doi:10.1038/nature01343)
26. Arnold, M. E., Paton, D. J., Ryan, E., Cox, S. J. & Wilesmith, J. W. 2008 Modelling studies to estimate the prevalence of foot-and-mouth disease carriers after reactive vaccination. Proc. R. Soc. B 275, 107-115. (doi:10.1098/rspb.2007.1154)
27. Paton, D. J., Valarcher, J.-F., Bergmann, I., Matlho, O. G., Zakharov, V. M., Palma, E. L. & Thomson, G. R. 2005 Selection of foot-and-mouth disease vaccine strains-a review. Sci. Tech. Rev. 24, 981-993.
28. McCullough, K. C., De Simone, F., Brocchi, E., Capucci, L., Crowther, J. R. & Kihm, U. 1992 Protective immune response against foot-and-mouth disease. J. Virol. 66, 1835-1840.
29. Parida, S. et al. 2006 Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. Vaccine 24, 964-969. (doi:10. 1016/j.vaccine.2005.08.108)
30. Juleff, N. et al. 2009 Foot-and-mouth disease virus can induce a specific and rapid CD4{thorn} T-cell-independent neutralizing and isotype class-switched antibody response in naive cattle. J. Virol. 83, 3626-3636. (doi:10.1128/JVI.02613-08)
31. Juleff, N., Windsor, M., Reid, E., Seago, J., Zhang, Z., Monaghan, P., Morrison, I. W. & Charleston, B. 2008 Foot-and-mouth disease virus persists in the light zone of germinal centres. PLoS ONE 3, e3434. (doi:10. 1371/journal.pone.0003434)
32. Brehm, K. E., Kumar, N., Thulke, H. H. & Haas, B. 2008 High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine 26, 1681-1687. (doi:10.1016/j.vaccine. 2008.01.038)
33. Blignaut, B., Visser, N., Theron, J., Rieder, E. & Maree, F.F. 2011 Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs. J. Gen. Virol. 92, 849-859. (doi:10.1099/vir.0.027151-0)
34. Li, Y., Stirling, C. M., Denyer, M. S., Hamblin, P., Hutchings, G., Takamatsu, H. H. & Barnett, P. V. 2008 Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost. Vaccine 19, 2647-2656. (doi:10.1016/j.vaccine.2008.01.037)
35. Wei, C.-J. et al. 2010 Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329, 1060-1064. (doi:10.1126/science.1192517)
36. Wu, L., Kong, W.-P. & Nabel, G. J. 2005 Enhanced breadth of CD4{thorn} T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens. J. Virol. 79, 8024-8031. (doi:10.1128/JVI.79.13.8024-8031.2005)
37. Parida, S., Mahapatra, M., Kumar, S., Das, S. C., Baron, M. D., Anderson, J. & Barrett, T. 2007 Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine. J. Gen. Virol. 88, 2019-2027. (doi:10.1099/vir.0.82913-0)
38. Mahapatra, M., Parida, S., Baron, M. D. & Barrett, T. 2006 Matrix protein and glycoproteins F and H of peste-des-petits-ruminants virus function better as a homologous complex. J. Gen. Virol. 87, 2021-2029. (doi:10.1099/vir.0.81721-0)
39. Diallo, A., Minet, C., Le Goff, C., Berhe, G., Albina, E., Libeau, G. & Barrett, T. 2007 The threat of peste des petits ruminants: progress in vaccine development for disease control. Vaccine 25, 5591-5597. (doi:10.1016/j. vaccine.2007.02.013)
40. Chen, W., Hu, S., Qu, L., Hu, Q., Zhang, Q., Zhi, H., Huang, K. & Bu, Z. 2010 A goat pox virus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep. Vaccine 28, 4642-4750.
41. Bhanuprakash, V., Indrani, B. K., Hosamani, M. & Singh, R. K. 2006 The current status of sheep pox disease. Comp. Immunol. Microbiol. Infect. Dis. 29, 27-60. (doi:10.1016/j.cimid.2005.12.001)
42. Leitão, A., Cartaxeiro, C., Coelho, R., Cruz, B., Parkhouse, R. M., Portugal, F., Vigário, J. D. & Martins, C. L. 2001 The non-haem adsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response. J. Gen. Virol. 82, 513-523.
43. Oura, C. A. L., Denyer, M. S., Takamatsu, H. & Parkhouse, R. M. E. 2005 In vivo depletion of CD8{thorn} T lymphocytes abrogates protective immunity in African swine fever virus. J. Gen. Virol. 86, 2445-2450. (doi:10. 1099/vir.0.81038-0)
44. Costard, S., Wieland, B., de Glanville, W., Jori, F., Rowlands, R., Vosloo, W., Roger, F., Pfeiffer, D. U. & Dixon, L. K. 2009 African swine fever: how can global spread be prevented? Phil. Trans. R. Soc. B 364, 2683-2696. (doi:10.1098/rstb.2009.0098)
45. Savini, G., MacLachlan, N. J., Sanchez-Vizcaino, J.-M. & Zientara, S. 2008 Vaccines against bluetongue in Europe. Comp. Immunol. Microbiol. Infect. Dis. 31, 101-120. (doi:10.1016/j.cimid.2007.07.006)
46. Jeggo, M. H., Wardley, R. C. & Taylor, W. P. 1983 Host response to bluetongue virus. In Double-stranded RNA viruses (eds R. W. Compans & D. H. L. Bishop), pp. 354-359. Amsterdam, The Netherlands: Elsevier Science.
47. Anderson, J., Mertens, P. P. & Herniman, K. A. 1993 A competitive ELISA for the detection of anti-tubule antibodies using monoclonal antibody against bluetongue virus non-structural protein NS1. J. Virol. Methods 43, 167-175. (doi:10.1016/0166-0934(93)90074-2)
48. Barros, S.C., Cruz, B., Luis, T.M., Ramos, F., Fagulha, T., Duarte, M., Henriques, M. & Fevereiro, M. 2009 A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus. Vet. Microbiol. 137, 252-259. (doi:10.1016/j.vetmic.2009.01.033)
49. Veronesi, E., Darpel, K. E., Hamblin, C., Carpenter, S., Takamatsu, H.-H., Anthony, S. J., Elliott, H., Mertens, P. P. C. & Mellor, P. S. 2010 Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4. Vaccine 28, 1397-1403. (doi:10.1016/j.vaccine. 2009.10.107)
50. Lobato, Z. I., Coupar, B. E., Gray, C. P., Lunt, R. & Andrew, M. E. 1997 Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens. Vet. Immunol. Immunopathol. 59, 293-309. (doi:10.1016/S0165-2427(97)00084-6)
51. Boone, J. D. et al. 2007 Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 25, 672-678. (doi:10. 1016/j.vaccine.2006.08.025)
52. Wade-Evans, A. M., Romero, C. H., Mellor, P., Takamatsu, H., Anderson, J., Thevasagayam, J., Fleming, M. J., Mertens, P. P. & Black, D. N. 1996 Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 220, 227-231. (doi:10.1006/viro.1996.0306)
53. Noad, R. & Roy, P. 2009 Bluetongue vaccines. Vaccine 27, D86-D89. (doi:10.1016/j.vaccine.2009.08.037)
54. Stewart, M. et al. 2010 Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus. Vaccine 28, 3047-3054. (doi:10. 1016/j.vaccine.2009.10.072)
55. Boyce, M., Celma, C. C. & Roy, P. 2008 Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts. J. Virol. 82, 8339-8348. (doi:10.1128/JVI.00808-08)
56. Bird, B. H., Albarino, C. G., Hartman, A. L., Erickson, B. R., Ksiazek, T. G. & Nichol, S. T. 2008 Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals. J. Virol. 82, 2681-2691. (doi:10.1128/JVI.02501-07)
57. Heise, M. T. et al. 2009 An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus. Epidemiol. Infect. 137, 1-10. (doi:10.1017/S095026880 8001696)
58. Wallace, D. B., Ellis, C. E., Espach, A., Smith, S. J., Greyling, R. R. & Viljoen, G. J. 2006 Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. Vaccine 24, 7181-7189. (doi:10.1016/j.vaccine.2006.06.041)
59. Liu, L., Celma, C. C. & Roy, P. 2008 Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. Virol. J. 5, 82. (doi:10.1186/1743-422X-5-82)
60. Näslund, J., Lagerqvist, N., Habjan, M., Lundkvist, A., Evander, M. & Ahlm, C. 2009 Vaccination with viruslike particles protects mice from lethal infection of Rift Valley fever virus. Virology 385, 409-415. (doi:10.1016/ j.virol.2008.12.012)
61. Li, Z. & Liu, J. 2011 The current state of vaccines used in the field for foot-and-mouth disease in China. Exp. Rev. Vaccines 10, 13-15. (doi:10.1586/erv.10.146)
62. Ohishi, K., Inui, K., Yamanouchi, K. & Barrett, T. 1999 Cell-mediated immune responses in cattle vaccinated with a vaccinia virus recombinant expressing the nucleocapsid protein of rinderpest virus. J. Gen. Virol. 80, 1627-1634.
63. Jeggo, M. H., Wardley, R. C. & Brownlie, J. 1984 A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques. Immunology 52, 403-410.
64. Jeggo, M.H., Wardley, R. C. & Brownlie, J. 1985 Importance of ovine cytotoxic T cells in protection against bluetongue virus infection. Prog. Clin. Biol. Res. 178, 477-487.
65. Schmaljohn, C. S., Parker, M. D., Ennis, W. H., Dalrymple, J. M., Collett, M. S., Suzich, J. A. & Schmaljohn, A. L. 1989 Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. Virology 170, 184-192. (doi:10.1016/0042-6822(89)90365-6)
66. Pepin, M., Bouloy, M., Bird, B. H., Kemp, A. & Paweska, J. 2010 Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet. Res. 41, 61. (doi:10.1051/vetres/2010033)